摘要
目的:探究丙泊酚对白细胞介素-6(IL-6)诱导的A549肺癌细胞上皮间质转化(EMT)的作用及机制。方法:将A549细胞随机分成四组:对照组、IL-6组(50 ng/ml重组IL-6蛋白)、IL-6+丙泊酚低剂量组(50 ng/ml重组IL-6蛋白和5μmol/L丙泊酚)、IL-6+丙泊酚高剂量组(50 ng/ml重组IL-6蛋白和10μmol/L丙泊酚)。MTT法检测细胞活力,Transwell检测细胞迁移情况,Real-time PCR方法检测EMT相关基因(E-cadherin、Vimentin和Snail1)mRNA的表达水平,Western blot检测EMT相关蛋白及JAK2和STAT3的磷酸化表达水平。使用0.5μmol/L STAT3激活剂colivelin处理细胞,检测其对丙泊酚调节的IL-6诱导的A549细胞活力、迁移和EMT的影响。结果:与对照组相比,IL-6组中细胞的活力、迁移、EMT和JAK2/STAT3的活化均增加(P均<0.05);与IL-6组相比,IL-6+丙泊酚组中细胞活力、迁移、EMT和JAK2/STAT3的活化均降低(P均<0.05),这些变化均具有剂量依赖性。STAT3激活剂能够减弱丙泊酚对IL-6诱导的A549细胞活力、迁移和EMT的影响(P均<0.05)。结论:丙泊酚能够抑制IL-6诱导的A549肺癌细胞EMT进程,这种作用是通过抑制JAK2/STAT3的活化发挥作用的。
Objective: To investigate the role and mechanism of propofol on interleukin-6( IL-6)-induced epithelial-mesenchymal transition( EMT) of A549 lung cancer cells. Methods: A549 cells were randomly divided into four groups: Control group,IL-6 group( 50 ng/ml recombinant IL-6 protein),IL-6 + propofol( low) group( 50 ng/ml recombinant IL-6 protein and 5 μmol/L propofol),and IL-6 + propofol( high) group( 50 ng/ml recombinant IL-6 protein and 10 μmol/L propofol). MTT was used to analyze cell viability. Cell migration was determined by Transwell assay. Real-time PCR was used to detect the mRNA expression of EMT-related genes( E-cadherin,Vimentin,and Snail1). Western blot was used to measure the levels of EMT-related proteins and the phosphorylation of JAK2 and STAT3. Additionally,we also determined the role of 0. 5 μmol/L STAT3 activator colivelin on propofol-mediated the proliferation,migration,and EMT induced by IL-6. Results: Compared with control group,cell viability,migration,EMT,and the activation of JAK2/STAT3 were increased in IL-6 group( P all 〈0. 05). Compared with IL-6 group,cell viability,migration,EMT,and the activation of JAK2/STAT3 were decreased in IL-6 + propofol group( P all 〈0. 05) in a dose-dependent manner. STAT3 activator could attenuate the effect of propofol on IL-6-induced cell viability,migration,and EMT( P all〈 0. 05). Conclusion: Propofol could suppress IL-6-induced A549 lung cancer cell EMT via inhibiting the activation of JAK2/STAT3.
作者
司海超
司小萌
高毅
张新科
郭培霞
刘展
马婕妤
Si Haichao;Si Xiaomeng;Gao Yi;Zhang Xinke;Guo Peixia;Liu Zhan;Ma Jieyu(Department of Anesthesiology,Nanyang Central Hospital,Henan Nanyang 473000,China;Department of Anesthesiology,Zhengzhou Central Hospital,Henan Zhengzhou 450000,China)
出处
《现代肿瘤医学》
CAS
2018年第14期2163-2168,共6页
Journal of Modern Oncology